Cytovation As

This early-phase study tested a new drug called CyPep-1, injected directly into tumors, combined with the immunotherapy pembrolizumab. It included 6 people with advanced head and neck, melanoma, or triple-negative breast cancers. The main goals were to check safety and see if the…

This early-phase trial tested a new drug, CyPep-1, injected directly into tumors in 60 people with advanced solid cancers that had stopped responding to standard treatments. The study looked at safety and whether the drug, given alone or with the immunotherapy pembrolizumab, coul…